QA: BELLICUM PHARMACEUTICALS INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001358403_2023_BELLICUM_PHARMACEUTICALS_INC.pdf

Logs

Graph

Absolute values for 0001358403, BELLICUM PHARMACEUTICALS INC

  xvar xval
0 AssetsCurrent 23,801,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 22,000
3 remainder_Assets 0
4 LiabilitiesCurrent 3,772,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,717,000
9 ResearchAndDevelopmentExpense 22,764,000
10 remainder_Expenses 2,000
11 remainder_Revenues 1,500,000
12 remainder_NetIncome 2,010,000
13 remainder_ComprehensiveNetIncome -16,000
  yvar yval
0 Assets 23,823,000
1 Liabilities 3,772,000
2 Expenses 28,483,000
3 Revenues 1,500,000
4 StockholdersEquity 20,051,000
5 NetIncome -24,973,000
6 ComprehensiveNetIncome -24,981,000
7 BaseVar 29,802,000
8 EconomicCapitalRatio 0.689

Edgar->Model Mapping

Feature Distribution

Change over Time